P

Inventor

COLE DEREK CECIL

US35 patents
⚠️ This page may combine multiple inventors who share the name “COLE DEREK CECIL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WYETH CORP

25 patents
US7300951B2Nov 27, 2007

Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof

WYETH CORP43 citations94
US7041695B2May 9, 2006

N-sulfonylheterocyclopyrrolyl-alkylamine compounds as 5-hydroxytryptamine-6 ligands

WYETH CORP19 citations92
US7034029B2Apr 25, 2006

1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands

WYETH CORP23 citations92
US6770642B2Aug 3, 2004

Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands

WYETH CORP23 citations92
US6767912B2Jul 27, 2004

Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands

WYETH CORP34 citations92
US7488832B2Feb 10, 2009

Azolylacylguanidines as β-secretase inhibitors

WYETH CORP19 citations89
US6951881B2Oct 4, 2005

(1-substituted-indol-3-yl) alkylidenehydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands

WYETH CORP21 citations86
US7585876B2Sep 8, 2009

Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands

WYETH CORP8 citations84
US6903112B2Jun 7, 2005

Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands

WYETH CORP14 citations84
US6800764B2Oct 5, 2004

Process for the synthesis of chirally pure beta-amino-alcohols

WYETH CORP17 citations82
US6906095B2Jun 14, 2005

Indolylalkylidenehydrazine-carboximidamide derivatives as 5-hydroxytryptamine-6 ligands

WYETH CORP17 citations79
US7282495B2Oct 16, 2007

1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands

WYETH CORP8 citations74
US7297705B2Nov 20, 2007

Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands

WYETH CORP8 citations73
US7022701B2Apr 4, 2006

Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands

WYETH CORP10 citations73
US6800640B2Oct 5, 2004

Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands

WYETH CORP9 citations73
US7547725B2Jun 16, 2009

Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof

WYETH CORP6 citations71
US7557098B2Jul 7, 2009

1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands

WYETH CORP1 citations63
US7541370B2Jun 2, 2009

1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands

WYETH CORP1 citations63
US7291736B2Nov 6, 2007

Sulfonyldihydroimidazopyridinone compounds as 5-hydroxytryptamine-6 ligands

WYETH CORP4 citations63
US7220756B2May 22, 2007

N-sulfonylheterocyclopyrrolyl-alkylamine compounds as 5-hydroxytryptamine-6 ligands

WYETH CORP2 citations63
US7288561B2Oct 30, 2007

Sulfonyltetrahydro-3H-benzo(E)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands

WYETH CORP3 citations62
US7420001B2Sep 2, 2008

Biaryl sulfonamides and methods for using same

WYETH CORP2 citations58
US7608717B2Oct 27, 2009

Sulfonyldihydroimidazopyridinone compounds as 5-hydroxytryptamine-6 ligands

WYETH CORP0 citations52
US7671075B2Mar 2, 2010

Substituted phenylsulfonamide inhibitors of beta amyloid production

WYETH CORP1 citations48
US7544701B2Jun 9, 2009

Sulfonyldihydrobenzimidazolone compounds as 5-hydroxytryptamine-6 ligands

WYETH CORP0 citations42

WYETH LLC

6 patents

AMERICAN CYANAMID CO

2 patents

ARQULE INC

1 patent

TAKEDA PHARMACEUTICALS CO

1 patent